Home/ Stocks/ IMDX

Insight Molecular Diagnostics Inc. Common Stock

IMDX XNAS

$5.01 -0.05 (-1.01%) ▼ 15-min delayed

Open

$4.87

High

$5.10

Low

$4.55

Volume

422.2K

Market Cap

$161.76M

About Insight Molecular Diagnostics Inc. Common Stock

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 58 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$4.05M	$-50,222,000	$-1.65
FY 2025	$4.05M	$-50,222,000	$-1.65
Q3 2025	$260.0K	$-10,854,000	$-0.34
Q2 2025	$518.0K	$-9,742,000	$-0.30

Related Market News

No specific coverage for IMDX yet. Check out our latest market news or earnings calendar.

Get IMDX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Insight Molecular Diagnostics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.